American Oncology Network Inc. Capital Reinvestment Ratio

Latest as of December 2024: 0.53x

American Oncology Network Inc. capital reinvestment ratio. American Oncology Network Inc. (AONC) has a Capital Reinvestment Ratio of 0.53x as of December 2024, meaning it reinvests 1% of its operating cash flow ($11.93 Million) in capital expenditures ($6.33 Million). See cash generation quality of American Oncology Network Inc. to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.53x
Capex / Operating Cash Flow

Operating Cash Flow

$11.93 Million
USD

Capital Expenditures

$6.33 Million
USD

Data as of

Dec 2024
Most recent filing

Capital Reinvestment Ratio of American Oncology Network Inc. (2020–2020)

Capital reinvestment ratio of American Oncology Network Inc. from 2020 to 2020. This chart tracks American Oncology Network Inc.'s Capital Reinvestment Ratio across 1 annual periods. See AONC financial flexibility index to measure the company's free cash flow as a share of total liabilities.

American Oncology Network Inc. Capital Reinvestment Ratio by Year (2020–2020)

American Oncology Network Inc. capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see AONC cash flow conversion.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 0.33x $37.24 Million $12.22 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow